Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Meglumine antimoniate
Introduction
| Meglumine Antimoniate |
|---|
| GLUCANTIM® WHO Prescribing Information |
| Description |
| Indications and Usage |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Dosage and Administration |
| How Supplied |
Synonyms and keywords: Meglumine antimonate
Overview
Overview
Meglumine antimoniate is a medicine used for treating leishmaniasis. It is manufactured by Aventis and sold as Glucantime in France, and Glucantim in Italy.
It belongs to a group of compounds known as the pentavalent antimonials. It is administered by intramuscular injection.
Category
Category
Antiparasitic
Brand Names
Brand Names
GLUCANTIM®, GLUCANTIME® (NOT AVAILABLE)
WHO Model Prescribing Information
WHO Model Prescribing Information
Description | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Dosage and Administration | How Supplied
Mechanism of Action
Mechanism of Action
The mechanism of action of meglumine antimoniate is unknown, but may involve inhibition of the parasite’s glycolytic and fatty acid oxidative activity resulting in decreased reducing equivalents for antioxidant defense and decreased synthesis of adenosine triphosphate.
References
References
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]